MAP2K1 and lung cancer: To assess the impact of beclin-1 on MEK1 activation, we analyzed the correlation between beclin-1 expression and MEK1 phosphorylation in a cohort of lung cancer patients that had altered levels of beclin-1 protein expression as measured by reverse-phase protein array (RPPA) [31, 32].